Jaguar Health (JAGX) Projected to Post Earnings on Tuesday

Jaguar Health (NASDAQ:JAGX) is expected to be posting its Q1 2025 quarterly earnings results before the market opens on Tuesday, May 13th. Analysts expect Jaguar Health to post earnings of ($18.50) per share and revenue of $3.29 million for the quarter.

Jaguar Health Price Performance

Shares of Jaguar Health stock opened at $8.51 on Monday. The company has a quick ratio of 1.36, a current ratio of 1.84 and a debt-to-equity ratio of 1.65. The company has a fifty day moving average price of $8.00 and a 200 day moving average price of $18.19. Jaguar Health has a twelve month low of $4.02 and a twelve month high of $502.35.

Analyst Ratings Changes

Separately, StockNews.com started coverage on shares of Jaguar Health in a research report on Friday, March 28th. They issued a “sell” rating for the company.

About Jaguar Health

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.